5Johnson MA, Jenkins JM, Bye C. A study of the pharmacokinetic interaction between lamivudine and alpha interferon[J]. Eur J Clin Pharmacol , 2000,56:289
6Julio M, Orencio B, Gloria M, et al. Pilot study of recombinant human granuloeyte-maerophayge colony-stimulatingfaetor in the treatment of hepatitis B [ J ]. Hepatology , 1993,18:775
7Lau GK, Tsiang M, Hou J, et al. Combination theraphy with lamivudine and fameielovir for chronic hepatitis B-infected. Chinese patients: a viral dynamics study [ J]. Hepatology , 2000,32:394
8Alter MJ. Epidemiology and prevention of hepatitis B [ J ]. Semin Liver Dis ,2003,23:39
9Janssen HL, Gerken G, Carreno V, et al. Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European concerted action on viral hepatitis B [ J ].Hepatology ,1999,30( 1 ) :238.
10Tompkins WA. Immunomodulation and the rapeutic effects of oral use of interferon alpha: mechanism of action [ J ]. Interferon Cytokine Res , 1999,19 ( 8 ) :817.
